Press releases

IRVINE, Calif., May 24, 2018 -- Edwards Lifesciences Corporation (NYSE: EW), the global leader in patient-focused innovations for structural heart disease and critical care monitoring, is scheduled to present at the Bernstein 34th Annual Strategic Decisions Conference at the Grand Hyatt New York on Thursday, May 31, 2018.

Michael A. Mussallem, chief executive officer, is scheduled to speak to conference attendees at 2:00 p.m. ET.  A live webcast of the presentation will be available to all interested parties on the Edwards Lifesciences investor relations website at http://ir.edwards.com/events.cfm.  An archived version of the webcast will be available later that day on the Edwards investor relations website in the News and Events section and via the Edwards Lifesciences Investor Relations App for mobile devices.

About Edwards Lifesciences

Edwards Lifesciences, based in Irvine, Calif., is the global leader in patient-focused medical innovations for structural heart disease, as well as critical care and surgical monitoring.  Driven by a passion to help patients, the company collaborates with the world's leading clinicians and researchers to address unmet healthcare needs, working to improve patient outcomes and enhance lives. For more information, visit www.Edwards.com and follow us on Twitter at @EdwardsLifeSci.

Edwards, Edwards Lifesciences, and the stylized E logo are trademarks of Edwards Lifesciences Corporation.

 

# # #